Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experienceChiara Ciochetto, Umberto Vitolo, Giulia Benevolo et al.|Annals of Hematology|2018Cited by 7
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia: Results of a Single-Center StudyDavide Stella, Luisa Giaccone, Jessica Gill et al.|Hematology Reports|2024Cited by 1